摘要：

The invention is directed to a patch for the transdermal delivery of the racemic form or the active enantiomer of the analgesic ketorolac. The transdermal patch is capable of delivering therapeutically effective doses of the drug for a period of 12 hours or more. The patch is capable of delivering the racemate of ketorolac at a flux rate of 40 &mgr;g/cm.sup. 2 ·hr or more, and of the active enantiomer at a flux rate of 20 &mgr;g/cm.sup.2 ·hr or more.

展开